Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Hospitaler/afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Søg efter ekspertise, navn eller tilknytning
Simon Tarp
External researcher, MSc, PhD
,
Bispebjerg og Frederiksberg Hospital
,
Parker Instituttet
2012
2024
Publikationer pr. år
Vis
Fingeraftryk
Netværk
Publikationer
(45)
Lignende profiler
(6)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Simon Tarp er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Keyphrases
Meta-analysis
100%
Systematic Meta-analysis
85%
Randomized Trial
79%
Rheumatoid Arthritis
63%
Network Meta-analysis
44%
Biological Agents
40%
Placebo
30%
Serious Adverse Events
29%
Risk of Bias
28%
Standardized Mean Difference
27%
Meta-analysis of Randomized Controlled Trials
26%
Meta-epidemiological Study
26%
Confidence Interval
23%
Randomized Controlled Trial
22%
MEDLINE
20%
Adverse Events
20%
Contextual Factors
19%
Antipsychotics
19%
Rheumatoid Arthritis Patients
17%
Embase
17%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
16%
Treatment Effect
15%
Grading of Recommendations
14%
Inflammatory Arthritis
13%
Prospero
13%
Adolescents with Autism Spectrum Disorder
13%
Comparative Effectiveness
13%
Hand Osteoarthritis
13%
Childhood Autism
13%
Monotherapy
13%
Targeted Therapy
13%
Systemic Juvenile Idiopathic Arthritis (sJIA)
13%
Modified Intention-to-treat
13%
Schizophrenia Spectrum Disorders
13%
Trial Results
13%
Intention-to-treat
12%
Cochrane
12%
Risk of Harm
12%
Evaluation Assessment
12%
Assessment Development
12%
Odds Ratio
12%
Disease-modifying Antirheumatic Drugs (DMARDs)
12%
Osteoarthritis
12%
Systematic Literature Review
12%
Tocilizumab
10%
Psoriatic Arthritis
10%
Certainty of Evidence
9%
Risk of Bias Tool
9%
Rheumatic Diseases
9%
Inconsistency
9%
Medicine and Dentistry
Systematic Review
67%
Meta-Analysis
65%
Rheumatoid Arthritis
41%
Adverse Event
27%
Randomized Controlled Trial
21%
Placebo
21%
Odds Ratio
16%
Network Meta-Analysis
16%
Intention-to-Treat Analysis
16%
Osteoarthritis
16%
Biological Product
14%
Targeted Therapy
14%
Glucocorticoid
13%
Hand Osteoarthritis
13%
Clinical Guideline
13%
Effect Size
11%
Treatment Effect
10%
Disease Modifying Antirheumatic Drug
10%
Arm
9%
Nonsteroid Antiinflammatory Agent
9%
Spondylarthritis
8%
Disease
8%
Psoriatic Arthritis
8%
Spinal Manipulation
6%
Clinical Decision Making
6%
Periodontal Treatment
6%
Hip
6%
Systemic Juvenile Idiopathic Arthritis
6%
Schizophrenia Spectrum Disorder
6%
Adolescent
6%
Rehabilitation Engineering
6%
Radiculopathy
6%
Factor A
6%
Gluten Free Casein Free Diet
6%
Intervention Trial
6%
Hip Osteoarthritis
6%
Total Hip Arthroplasty
6%
Physiotherapy for Pain
6%
Anodyne
6%
Physiotherapy
6%
Conservative Treatment
6%
Low Back Pain
6%
Pervasive Developmental Disorder
6%
Psoriasis
5%
Disease-Modifying Antirheumatic Drug
5%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
56%
Adverse Event
55%
Biological Product
39%
Randomized Controlled Trial
26%
Placebo
24%
Glucocorticoid
14%
Disease Modifying Antirheumatic Drug
13%
Monotherapy
13%
Antipsychotic
13%
Tocilizumab
9%
Disease
9%
Psoriatic Arthritis
9%
Rheumatic Disease
9%
Symptom
8%
Etanercept
7%
Osteoarthritis
7%
Typical Antipsychotic
7%
Methotrexate
7%
Prolactin
7%
Arthritis
7%
Musculoskeletal Disease
6%
Low Back Pain
6%
Intervention Trial
6%
Impulse Control Disorder
6%
Hyperprolactinemia
6%
Systemic Juvenile Idiopathic Arthritis
6%
Solid Malignant Neoplasm
6%
Ginger
6%
Anxiolytic
6%
Radiculopathy
6%
Juvenile Rheumatoid Arthritis
6%
Nalmefene
6%
International Classification of Diseases
6%
Bone Metastasis
6%
Bisphosphonic Acid Derivative
6%
Analgesic Agent
6%
Schizophrenia Spectrum Disorder
6%
Psoriasis
5%
Abatacept
5%
Rituximab
5%
